{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:20:02Z","timestamp":1773116402729,"version":"3.50.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1093\/rheumatology\/key180","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T11:12:35Z","timestamp":1528715555000},"page":"1812-1821","source":"Crossref","is-referenced-by-count":24,"title":["Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1093","volume":"57","author":[{"given":"Gwenny M","family":"Verstappen","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rada V","family":"Moerman","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolien F","family":"van Nimwegen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha S","family":"van Ginkel","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Bijzet","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Mossel","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjan","family":"Vissink","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bouke P C","family":"Hazenberg","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Arends","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans G M","family":"Kroese","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrika","family":"Bootsma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"key":"key\n\t\t\t\t20180924092230_key180-B1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/1744666X.2014.891439","article-title":"B-cell hyperactivity in primary Sjogren\u2019s syndrome","volume":"10","author":"Kroese","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"key\n\t\t\t\t20180924092230_key180-B2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/art.40059","article-title":"Enhanced Bruton\u2019s tyrosine kinase activity in peripheral blood B lymphocytes from patients with autoimmune disease","volume":"69","author":"Corneth","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t20180924092230_key180-B3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sjogren Syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180924092230_key180-B4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clim.2017.05.002","article-title":"The value of rituximab treatment in primary Sj\u00f6gren\u2019s syndrome","volume":"182","author":"Verstappen","year":"2017","journal-title":"Clin Immunol"},{"key":"key\n\t\t\t\t20180924092230_key180-B5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary Sjogren syndrome with rituximab: a randomized trial","volume":"160","author":"Devauchelle-Pensec","year":"2014","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180924092230_key180-B6","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.40093","article-title":"Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sj\u00f6gren\u2019s Syndrome","volume":"69","author":"Bowman","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t20180924092230_key180-B7","doi-asserted-by":"crossref","first-page":"e59868","DOI":"10.1371\/journal.pone.0059868","article-title":"Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjogren\u2019s syndrome. Data at enrollment in the prospective ASSESS cohort","volume":"8","author":"Gottenberg","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180924092230_key180-B8","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.39315","article-title":"CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sj\u00f6gren\u2019s Syndrome","volume":"67","author":"Nocturne","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t20180924092230_key180-B9","author":"Bradwell","year":"2010"},{"key":"key\n\t\t\t\t20180924092230_key180-B10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1164\/rccm.201104-0761OC","article-title":"An association between neutrophils and immunoglobulin free light chains in the pathogenesis of chronic obstructive pulmonary disease","volume":"185","author":"Braber","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180924092230_key180-B11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2362.2003.01191.x","article-title":"Immunoglobulin light chains modulate polymorphonuclear leucocyte apoptosis","volume":"33","author":"Cohen","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"key\n\t\t\t\t20180924092230_key180-B12","doi-asserted-by":"crossref","first-page":"e40986","DOI":"10.1371\/journal.pone.0040986","article-title":"Antigen binding characteristics of immunoglobulin free light chains: crosslinking by antigen is essential to induce allergic inflammation","volume":"7","author":"Thio","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180924092230_key180-B13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ard.2006.052159","article-title":"Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren\u2019s syndrome","volume":"66","author":"Gottenberg","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180924092230_key180-B14","doi-asserted-by":"crossref","first-page":"e0138753","DOI":"10.1371\/journal.pone.0138753","article-title":"Elevated concentrations of serum immunoglobulin free light chains in systemic lupus erythematosus patients in relation to disease activity, inflammatory status, B cell activity and Epstein-Barr virus antibodies","volume":"10","author":"Draborg","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180924092230_key180-B15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/acr.20446","article-title":"Serum free light chains as biomarkers for systemic lupus erythematosus disease activity","volume":"63","author":"Aggarwal","year":"2011","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t20180924092230_key180-B16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF00918666","article-title":"Clinical relapse in systemic lupus erythematosus: correlation with antecedent elevation of urinary free light-chain immunoglobulin","volume":"9","author":"Hopper","year":"1989","journal-title":"J Clin Immunol"},{"key":"key\n\t\t\t\t20180924092230_key180-B17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s Syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t20180924092230_key180-B18","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","article-title":"Effectiveness of rituximab treatment in primary Sj\u00f6gren\u2019s syndrome: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Meijer","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180924092230_key180-B19","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","article-title":"Abatacept treatment reduces disease activity in early primary Sjogren\u2019s syndrome (open-label proof of concept ASAP study)","volume":"73","author":"Meiners","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180924092230_key180-B20","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1136\/annrheumdis-2015-208504","article-title":"Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies","volume":"75","author":"Seror","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180924092230_key180-B21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180924092230_key180-B22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0895-4356(99)00206-1","article-title":"Methods for assessing responsiveness: a critical review and recommendations","volume":"53","author":"Husted","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20180924092230_key180-B23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00296-013-2885-y","article-title":"Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sj\u00f6gren\u2019s syndrome?","volume":"34","author":"Sudzius","year":"2014","journal-title":"Rheumatol Int"},{"key":"key\n\t\t\t\t20180924092230_key180-B24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren\u2019s Syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t20180924092230_key180-B25","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.20050068","article-title":"Among B cell non-Hodgkin\u2019s lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity","volume":"201","author":"Bende","year":"2005","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180924092230_key180-B26","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/ajh.23839","article-title":"Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma","volume":"89","author":"Witzig","year":"2014","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20180924092230_key180-B27","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1158\/1078-0432.CCR-04-0803","article-title":"Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma","volume":"10","author":"W\u00f6hrer","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20180924092230_key180-B28","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3899\/jrheum.110077","article-title":"Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren\u2019s syndrome: a retrospective clinical study","volume":"38","author":"Pollard","year":"2011","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20180924092230_key180-B29","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/art.39534","article-title":"Monoclonal gammopathy and risk of lymphoma and multiple myeloma in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"68","author":"Tomi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t20180924092230_key180-B30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2012.01.010","article-title":"Monoclonal gammopathy related to Sj\u00f6gren syndrome: a key marker of disease prognosis and outcomes","volume":"39","author":"Brito-Zer\u00f3n","year":"2012","journal-title":"J Autoimmun"},{"key":"key\n\t\t\t\t20180924092230_key180-B31","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180924092230_key180-B32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","article-title":"Characterization and risk estimate of cancer in patients with primary Sj\u00f6gren syndrome","volume":"10","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"J Hematol Oncol"},{"key":"key\n\t\t\t\t20180924092230_key180-B33","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/annonc\/mdx025","article-title":"Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma","volume":"28","author":"Teckie","year":"2017","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180924092230_key180-B34","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1136\/ard.2009.126441","article-title":"Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity","volume":"69","author":"Kormelink","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180924092230_key180-B35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10067-010-1674-1","article-title":"Normalization of serum-free light chains in patients with systemic lupus erythematosus upon rituximab treatment and correlation with biological disease activity","volume":"30","author":"Chiche","year":"2011","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t20180924092230_key180-B36","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/art.40165","article-title":"Attenuation of follicular helper T cell-dependent B cell hyperactivity by abatacept treatment in primary Sj\u00f6gren\u2019s Syndrome","volume":"69","author":"Verstappen","year":"2017","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/57\/10\/1812\/25827513\/key180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T11:31:08Z","timestamp":1720351868000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/57\/10\/1812\/5048120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,2]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,7,2]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key180","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10]]},"published":{"date-parts":[[2018,7,2]]}}}